secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0001641489-24-000054
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics expands Newsoara license globally for $20M upfront, up to $96M milestones
--------------------------------------------------------------------------------

- Second Amendment to License Agreement with Newsoara Biopharma expands original China license to global.
- Newsoara to pay $20M upfront within one year; if not paid, amendment void.
- Up to $41M in development milestones and $35M in sales milestones, plus mid-to-upper single-digit royalties.
- vTv Therapeutics LLC (subsidiary of vTv Therapeutics Inc.) is the licensor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000054/0001641489-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000054/vtvt-20240626.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer